Search results
Ani Pharmaceuticals executive sells over $2.3 million in company stock By Investing.com
Investing.com· 3 hours agoANI Pharmaceuticals Inc. (NASDAQ:ANIP) has reported a significant transaction involving its...
Telix Pharmaceuticals plans Nasdaq listing By Investing.com
Investing.com· 8 hours agoTelix Pharmaceuticals Limited (ASX: TLX), an Australian biopharmaceutical company, has filed a...
Earnings Release: Here's Why Analysts Cut Their Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Price...
Simply Wall St. via Yahoo Finance· 7 days agoMarinus Pharmaceuticals, Inc. (NASDAQ:MRNS) just released its latest first-quarter report and things...
CNS Pharmaceuticals (NASDAQ: CNSP) Releases Q1 2024 Financial, Business Report
Digital Journal· 8 hours agoPRESS RELEASE Published May 17, 2024 InvestorBrandNetwork CNS Pharmaceuticals (NASDAQ: CNSP) , a biopharmaceutical company specializing in the development ...
Ionis, Biogen Down on Ending Development of ALS Drug - Biogen (NASDAQ:BIIB), Heron Therapeutics (...
Benzinga· 6 hours agoShares of Ionis Pharmaceuticals (NASDAQ: IONS) and Biogen (NASDAQ: BIIB) lost at least 2% in market...
Phio Pharmaceuticals secures investment from TRITON Funds By Investing.com
Investing.com· 8 hours agoPhio Pharmaceuticals Corp. (NASDAQ:PHIO), a biotech firm focused on developing immune-based cancer...
Marinus Pharmaceuticals completes TrustTSC trial enrollment By Investing.com
Investing.com· 8 hours agoMarinus (NASDAQ:MRNS) Pharmaceuticals, Inc. (NASDAQ:MRNS), a company specializing in the development...
Zacks Small Cap Weighs in on MIRA Pharmaceuticals, Inc.’s FY2026 Earnings (NASDAQ:MIRA)
ETF DAILY NEWS· 20 hours agoMIRA Pharmaceuticals, Inc. (NASDAQ:MIRA – Free Report) – Equities researchers at Zacks Small Cap issued their FY2026 earnings per share (EPS) estimates ...
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Expected to Earn Q1 2025 Earnings of ($1.16) Per Share
ETF DAILY NEWS· 20 hours agoInovio Pharmaceuticals, Inc. (NASDAQ:INO – Free Report) – Research analysts at HC Wainwright issued their Q1 2025 EPS estimates for Inovio Pharmaceuticals ...
Leonard S. Schleifer Sells 25,000 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock
ETF DAILY NEWS· 21 hours agoRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) CEO Leonard S. Schleifer sold 25,000 shares of Regeneron Pharmaceuticals